#EJSACTPD

EJS ACT-PD

@ejs-act-pd.bsky.social

1 month ago

🎉 Big news from the #EJSACTPD team!

We have 7 abstracts accepted at World PD Congress 2026 🎉

Showcasing our innovative MAMS trial, inclusive recruitment, patient & public involvement and #JoinParkinsonsResearch registry hosted by @ResearchPlusMe 🙌

#WPC2026 @worldpdcongress.bsky.social

40:40 Recruitment - celia@4040recruitment.co.uk

@4040rec.bsky.social

4 months ago

UK starts 'largest-ever' trial of possible Parkinson's drugs UK researchers have started a large-scale trial to test a battery of potential Parkinson's drugs to see if they can slow down disease progression

#ParkinsonsDisease #Parkinsonstherapies #baskettrial #EJSACTPD #repurposedpharmaceuticals #Parkinsonstreatments #UCL #MRC #NIHR #CureParkinsons #TheMichaelJFoxFoundation #ParkinsonsUK #TheJohnBlackCharitableFoundation #TheGatsbyCharitableFoundation #VanAndelInstitute
zurl.co/EOu6m

UCL News

@uclnews.bsky.social

4 months ago

Largest-ever Parkinson’s disease trial opens across UK The world’s largest-ever clinical trial of treatments to slow or stop the progression of Parkinson’s disease has launched, led by researchers at UCL and Newcastle University.

The world’s largest-ever clinical trial of treatments to slow or stop the progression of Parkinson’s disease has launched, led by researchers at @uclqsion.bsky.social @uclh.bsky.social and @newcastleuni.bsky.social, accelerating the search for effective treatments in a £26 million project #ejsactpd

MRC Clinical Trials Unit at UCL

@mrcctu.bsky.social

5 months ago

Largest-ever Parkinson’s disease trial opens across UK | MRC Clinical Trials Unit at UCL

🚨Big news in Parkinson’s research!

We are excited to share that the largest-ever Parkinson’s disease trial has launched across the UK. Using our multi-arm, multi-stage #MAMS design, the #ejsactpd trial aims to stop or slow the progression of the disease.

🔗 More www.mrcctu.ucl.ac.uk/news/news-st...